Mitochondrial Morphology Dynamics Remodel Metabolism and Affect TKI Sensitivity in EGFR ‐Mutated Lung Cancer
Cancer Science · 2026-11 · 117 (11) · 3022-3038
DOI: 10.1111/cas.70488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 13.08.2026. Verfasst von Yu Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Sheng Jing Hospital, China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Protein Kinase Inhibitors, Mitochondrial Dynamics, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Liaoning Provincial Natural Science Foundation, the Guangzhou Science and Technology Plan Project-2024 Municipal School (Institute) Enterprise Joint Funding Project, Liaoning Province Education Science 14th Five-Year Plan Project.
Abstract (Originalsprache)
EGFR‐mutant non‐small cell lung cancer patients often exhibit resistance to TKI therapy. This treatment resistance is a key factor affecting the efficacy of TKIs and a major bottleneck in cancer treatment. The potential underlying cause may be closely related to tumor cell metabolic reprogramming. In this study, we established an EGFR‐mutant lung cancer mouse model, isolating and culturing tumor primary cells to explore the cellular and molecular mechanisms of EGFR‐mutant lung cancer. Using techniques such as super‐resolution microscopy and RNA‐seq, we qualitatively and quantitatively analyzed the morphological changes of mitochondria within tumor cells following TKI treatment. Our results indicate that mitochondrial dynamics are remodeled toward increased mitochondrial fission during the early phase of TKI treatment. Furthermore, pharmacological inhibition of mitochondrial fission further sensitizes tumor cells to EGFR‐TKIs. Additionally, disrupting oxidative phosphorylation metabolism can increase the sensitivity of tumor cells to TKI treatment and reverse tumor cell resistance to TKI. Overall, these findings suggest that the metabolic reprogramming of mitochondrial OXPHOS in tumor cells mediates energy stress adaptation, altering their response to TKI treatment and providing new metabolic therapeutic targets to overcome EGFR‐TKI resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Sheng Jing Hospital, China Medical University, Shenyang, Liaoning, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong…
- China-Portugal Artificial Intelligence and Public Health Technologies Joint Laboratory, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Diseases, Guangdong Provincial Key Laboratory of Respiratory D…
- Department of Blood Transfusion, Nantong First People's Hospital/Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China.
- Department of Oncology, Sheng Jing Hospital, China Medical University, Shenyang, Liaoning, China.
ORCID-Profile: Jun Tang
Förderung
- Liaoning Provincial Natural Science Foundation
- the Guangzhou Science and Technology Plan Project-2024 Municipal School (Institute) Enterprise Joint Funding Project
- Liaoning Province Education Science 14th Five-Year Plan Project
- Tibet Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Zhao, Y., Liu, Y., Xie, M., Ye, Z., Huang, H., Yao, M., Zhou, F., Zhao, J., & Tang, J. (2026). Mitochondrial Morphology Dynamics Remodel Metabolism and Affect TKI Sensitivity in EGFR ‐Mutated Lung Cancer. Cancer Science, 117(11), 3022-3038. https://doi.org/10.1111/cas.70488
Vancouver
Zhao Y, Liu Y, Xie M, Ye Z, Huang H, Yao M, et al. Mitochondrial Morphology Dynamics Remodel Metabolism and Affect TKI Sensitivity in EGFR ‐Mutated Lung Cancer. Cancer Science. 2026;117(11):3022-3038. doi:10.1111/cas.70488
BibTeX
@article{Zhao2026,
author = {Zhao, Yu and Liu, Yuqiang and Xie, Mingxuan and Ye, Zhiming and Huang, Hong and Yao, Maojin and Zhou, Feng and Zhao, Jianzhu and Tang, Jun},
title = {Mitochondrial Morphology Dynamics Remodel Metabolism and Affect TKI Sensitivity in EGFR ‐Mutated Lung Cancer},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {11},
pages = {3022--3038},
doi = {10.1111/cas.70488}
}
EUVIMED